Ranbaxy Reports Loss Of Rs 2983 Crore In December Quarter

DSIJ Intelligence / 23 Feb 2012

Company has reported 78 per cent jump in its top line. Its net profit however has declined due to the Settlement provision of Rs 2648 crore

Pharma giant, Ranbaxy has come up with its December quarter and calendar year 2011 results. Company has reported 78 per cent jump in its top line. Its net profit however has declined due to the Settlement provision of Rs 2648 crore. Company has also suffered a Forex loss of Rs 83 crore against gain of Rs 13 crore in the December quarter of 2010.

Its sales from outside India increased by 123 per cent while that in the domestic market reported negative growth rate. Operational performance was good where EBITDA margins zoomed to 23 per cent from 11 per cent in the similar period in 2010.

Owing to the aforesaid provision, company has reported loss of Rs 2982.7 crore in the quarter.

For the year 2011, Ranbaxy has reported 13 per cent rise in the top line; EBITDA margins have taken a beating in its yearly performance. Net loss for the year was Rs 2899 crore.

The detailed results will follow shortly.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.